These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 917443)

  • 1. Cell kinetic studies of prostatic cancer: adjuvant therapy in animal models.
    Weissman RM; Coffey DS; Scott WW
    Oncology; 1977; 34(3):133-7. PubMed ID: 917443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental models for the study of prostatic adenocarcinoma.
    Smolev JK; Coffey DS; Scott WW
    J Urol; 1977 Jul; 118(1 Pt 2):216-20. PubMed ID: 875219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunobiology and therapeutic manipulation of heterotransplanted Nb rat prostate adenocarcinoma into congenitally athymic (nude) mice. I. Hormone dependency and histopathology.
    Drago JR; Gershwin ME; Maurer RE; Ikeda RM; Eckels DD
    J Natl Cancer Inst; 1979 Apr; 62(4):1057-66. PubMed ID: 285279
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of the transplantable adenocarcinoma (R-3327) of the Copenhagen rat.
    Block NL; Camuzzi F; Denefrio J; Troner M; Claflin A; Stover B; Politano VA
    Oncology; 1977; 34(3):110-3. PubMed ID: 917440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations on prostatic adenocarcinomas in rats.
    Pollard M; Chang CF; Luckert PH
    Oncology; 1977; 34(3):129-32. PubMed ID: 917442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of an androgen-dependent Nb rat prostate adenocarcinoma.
    Drago JR; Goldman LB; Maurer RE; Eckels DD; Gershwin ME
    J Natl Cancer Inst; 1980 Apr; 64(4):931-7. PubMed ID: 6929004
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.
    Vieweg J; Rosenthal FM; Bannerji R; Heston WD; Fair WR; Gansbacher B; Gilboa E
    Cancer Res; 1994 Apr; 54(7):1760-5. PubMed ID: 8137291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of complete versus partial androgen withdrawal therapy for the treatment of prostatic cancer as studied in the Dunning R-3327 system of rat prostatic adenocarcinomas.
    Ellis WJ; Isaacs JT
    Cancer Res; 1985 Dec; 45(12 Pt 1):6041-50. PubMed ID: 4063963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate tumor biology and cell kinetics--theory.
    Coffey DS; Isaacs JT
    Urology; 1981 Mar; 17(Suppl 3):40-53. PubMed ID: 7010755
    [No Abstract]   [Full Text] [Related]  

  • 10. The Nb rat prostatic adenocarcinoma model system.
    Drago JR; Goldman LB; Maurer RE
    Prog Clin Biol Res; 1980; 37():265-91. PubMed ID: 7384086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model systems for the study of prostatic cancer.
    Merchant DJ
    Oncology; 1977; 34(3):100-1. PubMed ID: 917437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of prostate cancer.
    Russell PJ; Voeks DJ
    Methods Mol Med; 2003; 81():89-112. PubMed ID: 12725117
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormonally responsive versus unresponsive progression of prostatic cancer to antiandrogen therapy as studied with the Dunning R-3327-AT and -G rat adenocarcinomas.
    Isaacs JT
    Cancer Res; 1982 Dec; 42(12):5010-4. PubMed ID: 6215981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An animal model for the study of prostate carcinoma.
    Lubaroff DM; Canfield L; Rasmussen GT; Reynolds CW
    Natl Cancer Inst Monogr; 1978 Dec; (49):275-81. PubMed ID: 748781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy and radiation of Nb rat prostatic adenocarcinoma: Nb Pr-A.I.-1.
    Drago JR; Goldman L; Gershwin ME
    J Surg Res; 1980 Jun; 28(6):492-6. PubMed ID: 7421169
    [No Abstract]   [Full Text] [Related]  

  • 16. Endocrine manipulation of the Dunning prostatic adenocarcinoma.
    Shessel FS; Block NL; Stover B; Claflin A; Malinin TI; Politano VA
    Invest Urol; 1980 May; 17(6):529-33. PubMed ID: 7372443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human prostatic adenocarcinoma: comparative experimental treatment of the tumor line PC 82 in nude mice.
    Hoehn W; Walther R; Hermanek P
    Prostate; 1982; 3(2):193-201. PubMed ID: 7088734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT.
    Isaacs JT; Heston WD; Weissman RM; Coffey DS
    Cancer Res; 1978 Nov; 38(11 Pt 2):4353-9. PubMed ID: 698976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of different combinations of estrogen therapy and radiation therapy on prostatic adenocarcinoma (R-3327).
    Camuzzi F; Block NL; Stover B; Gottlieb C; Charyulu K; Politano VA
    Urology; 1980 May; 15(5):443-7. PubMed ID: 7052707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between tumor size and the curability of metastatic prostatic cancer by surgery alone or in combination with adjuvant chemotherapy.
    Henry JM; Isaacs JT
    J Urol; 1988 May; 139(5):1119-23. PubMed ID: 3361656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.